Pregabalin Capsules, Cv
Product Images NDC 50090-5938

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin Capsules, Cv (NDC 50090-5938). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (03a1965c 9956 486f 8599 7f5ecbf6c3b5 01)

This appears to be a formula used for estimating creatinine clearance (CL) in adults based on their age, weight, and serum creatinine levels. The formula includes a variable for gender (represented by a factor of 0.85 for females), which suggests that it may be used differently for male and female patients. However, without additional context it is difficult to provide a more specific description or explanation of its use.*

FDA Label Image

Image (03a1965c 9956 486f 8599 7f5ecbf6c3b5 02)

FDA Label Image

Image (03a1965c 9956 486f 8599 7f5ecbf6c3b5 03)

This document appears to be a graph of patient improvement percentages related to pain. The x-axis lists numerical values ranging from 210 to 290, while the y-axis displays percentages ranging from 0 to 100. The title of the graph is "Percent Improvement in Pain from Baseline," and it appears that patient improvement percentages are plotted in relationship to various values on the x-axis. However, the text in the middle of the graph is not readable and may be a result of an error in .*

FDA Label Image

Image (03a1965c 9956 486f 8599 7f5ecbf6c3b5 04)

FDA Label Image

Image (03a1965c 9956 486f 8599 7f5ecbf6c3b5 05)

FDA Label Image

Image (03a1965c 9956 486f 8599 7f5ecbf6c3b5 06)

FDA Label Image

Image (03a1965c 9956 486f 8599 7f5ecbf6c3b5 07)

FDA Label Image

Image (03a1965c 9956 486f 8599 7f5ecbf6c3b5 08)

FDA Label Image

Image (03a1965c 9956 486f 8599 7f5ecbf6c3b5 09)

FDA Label Image

Figure (03a1965c 9956 486f 8599 7f5ecbf6c3b5 10)

This document appears to be a chart or graph displaying responder rates in a study. It shows a 60% responder rate and three additional percentages: 40.6%, 29.1%, and 226%. The chart also mentions a placebo and two dosage levels of medication, with percentages labeled as 2.5 and 10 mglkglday. It is unclear what the percentages labeled as "9" and "103 %" refer to.*

FDA Label Image

Image (03a1965c 9956 486f 8599 7f5ecbf6c3b5 11)

This is a chart that shows the percent of patients who improved from baseline pain levels for different doses of pregabalin and placebo. The chart includes values up to 100% improvement in pain and is not providing any additional information on the study or condition being treated.*

FDA Label Image

Image (03a1965c 9956 486f 8599 7f5ecbf6c3b5 12)

FDA Label Image

Image (03a1965c 9956 486f 8599 7f5ecbf6c3b5 13)

FDA Label Image

Image (03a1965c 9956 486f 8599 7f5ecbf6c3b5 14)

FDA Label Image

Label Image (Lbl500905938)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.